Nasal COVID Vax Shows Promise in Phase 1 Clinical Trial

Written by Bluelake Biotechnology

https://scienceblog.cincinnatichildrens.org/nasal-covid-vax-shows-promise-in-phase-1-clinical-trial/

Bluelake Biotechnology
Previous

Blue Lake and CyanVac Publish Full Data from Open Label Phase 1 Clinical Study of COVID-19 Vaccine Candidate
Next

Preclinical Intranasal COVID-19 Vaccine Candidate Data Demonstrate Durable Immune Response and Broad Protection